Immunotherapy-Induced Acute Gastritis: First Case Report of Nivolumab Re-Challenge after Severe Immune-Mediated Inflammatory Response. Archives of Clinical and Medical Case Reports, v. 6, n. 2, p. 182–188, 9 Mar.2022.